Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Ewing sarcoma is the prototype of round cell sarcoma whereas in CIC sarcomas, focal pleomorphism and epithelioid morphology can predominate.
|
31802230 |
2020 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
BCOR-rearranged sarcomas, CIC-fused sarcomas) and describes new groups with common characteristics.
|
30474142 |
2019 |
Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Results were compared to methylation data of 30 EwS with various EWSR1-ETS fusions and one EwS with FUS-ERG fusion, 16 URCS with CIC rearrangement and 10 URCS with BCOR alteration and a total of 81 EWSR1-associated soft tissue sarcomas including 7 angiomatoid fibrous histiocytomas, 7 clear cell sarcomas of the soft tissue, 28 desmoplastic small round cell tumors, 10 extraskeletal myxoid chondrosarcomas and 29 myxoid liposarcomas.
|
30895378 |
2019 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
CIC fusion-positive sarcoma of the spermatic cord.
|
30310990 |
2019 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
The diagnosis of sarcoma with CIC-DUX4 gene fusion is difficult in lack of specific pathological characteristics emphasizing the need for molecular analysis.
|
28466754 |
2019 |
Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Primitive round- or spindle-cell EWSR1-negative undifferentiated sarcomas harboring CIC-DUX4 gene fusion are the most common form of Ewing-like sarcomas.
|
28474974 |
2019 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
In light of morphologic features that overlap with those of NC from typical anatomical sites we have seen previously, the tumor was best classified as falling within the NC spectrum rather than CIC-associated sarcoma.
|
29700887 |
2018 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
The CIC-DUX4 sarcoma is a small round blue cell sarcoma which presents like extraskeletal Ewing sarcoma, but is negative for the EWSR1 gene translocation.
|
30353686 |
2018 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Herein, we describe the clinicopathologic features and comprehensive molecular profiling of 4 cases of primary renal CIC-rearranged sarcomas.
|
29901569 |
2018 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Unsupervised clustering by RNAseq data revealed that tumors with BCOR genetic alterations, including BCOR-CCNB3, BCOR-MAML3, and BCOR ITD, formed a tight genomic group distinct from ES and CIC-rearranged sarcomas.
|
29300189 |
2018 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
CIC-rearrangement by FISH was observed in many of the CIC-rearranged sarcomas.
|
29661713 |
2018 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Heterogeneous elements included a myxoid spindle cell component in three BCOR-CCNB3 sarcomas and an epithelioid cell component in two CIC-associated sarcomas (one CIC-DUX4-positive and one CIC-DUX4-negative sarcomas).
|
28197724 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
In conclusion, NKX2.2, ETV4 and BCOR IHC may be helpful in daily practice for distinguishing ESFT from CIC or BCOR-associated sarcomas, especially in hospitals without access to molecular assays.
|
28864350 |
2017 |
Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
We recognized the tumor as a genetically distinct variant of CIC-rearranged sarcomas with a novel NUTM2A-CIC fusion.
|
28188754 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
We estimated that the FISH false-negative rate for CIC-rearranged sarcomas was 14%.
|
28493604 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
No PAX7 expression was observed in any of 27 cases of CIC-DUX4 sarcoma by immunohistochemistry (0%; 0/27).
|
28643791 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
As such the WHO classification temporarily grouped the CIC-rearranged tumors under undifferentiated sarcomas with round cell phenotype, until further clinical evidence was available.
|
28346326 |
2017 |
Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements.
|
28233365 |
2017 |
Sarcoma
|
0.400 |
GeneticVariation
|
group |
BEFREE |
A recently characterized group of undifferentiated small round cell sarcomas harbours fusions of the genes CIC and DUX4.
|
27790742 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
This case report describes an additional case of <i>CIC-DUX4</i> sarcoma with a novel fusion breakpoint, and demonstrates the value of this next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) in both diagnosis for patient care and in identification of a novel fusion breakpoint in this tumour type.
|
28137728 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Gene silencing of <i>CIC-DUX4</i> as well as <i>Ccnd2, Ret</i>, and <i>Bcl2</i> effectively inhibited CDS tumor growth <i>in vitro</i> The CDK4/6 inhibitor palbociclib and the soft tissue sarcoma drug trabectedin also blocked the growth of mouse CDS.
|
28404587 |
2017 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
The CIC-DUX4 sarcoma is a subset of the undifferentiated small round cell sarcoma family, presently recognized as a new clinicopathological entity.
|
27919577 |
2017 |
Sarcoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In summary, diffuse moderate-to-strong ETV4 expression is present in most CIC-rearranged sarcomas and unclassified round cell sarcomas.
|
27443513 |
2016 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
A histologic comparison of the CIC-rearranged sarcomas with 20 EWSR1-rearranged Ewing sarcomas showed significantly higher degrees of lobulation, nuclear pleomorphism, the prominence of the nucleoli, spindle cell elements, and myxoid changes in the CIC-rearranged sarcomas.
|
26685084 |
2016 |
Sarcoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Gene fusions between CIC and DUX4 define a rare class of soft tissue sarcomas poorly understood at the molecular level.
|
27664537 |
2016 |